期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 137, 期 9, 页码 3233-3236出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.5b00757
关键词
-
资金
- NIH [R01 GM078240, P50 GM067041]
- Dainippon Sumitomo Pharma Co., Ltd.
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078240, P50GM067041] Funding Source: NIH RePORTER
Tartaric acid is an ideal asymmetric catalyst as it is abundant, cheap, and environmentally friendly. (+)-Tartaric acid was found to catalyze a novel enantioselective [4 + 2] cycloaddition of isochromene acetals and vinylboronates. A variety of substituted isochromene acetals were tolerated, furnishing the desired dihydronaphthalenes and dihydrobenzofluorene products in good yields. High enantiomeric ratios (up to 98.5:1.5) and excellent diastereoselectivities (all >99:1) were observed employing 10 mol % of (+)-tartaric acid as the catalyst, in combination with 5 mol % of Ho(OTf)(3).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据